Hematologic toxicity in BRCA1 and BRCA2 mutation carriers during chemotherapy: A retrospective matched cohort study

Women who inherit a BRCA1 or BRCA2 mutation have an increased risk of breast cancer. Preliminary evidence suggests they may also have defects in bone marrow function. To test this hypothesis, we conducted a multicenter, retrospective, matched cohort study, comparing women with localized breast cance...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Med
Main Authors: West, Allison H., Knollman, Hayley, Dugan, James, Hedeker, Donald, Handorf, Elisabeth A., Nielsen, Sarah M., Bealin, Lisa C., Goldblatt, Lindsay G., Willems, Heather, Daly, Mary B., Afghahi, Anosheh, Olopade, Olufunmilayo I., Hulick, Peter J., Shagisultanova, Elena, Huo, Dezheng, Obeid, Elias, Churpek, Jane E.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2019
Assuntos:
Clinical Cancer Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6745828/
https://ncbi.nlm.nih.gov/pubmed/31407530
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2471
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados